Showing results (501-510 of 2,168) with videos related to
Sort By:
Pageof 217
Journal of Biopharmaceutical Statistics|July 14, 2026
Nonparametric testing methods based on relative effect in non-inferiority clinical trial with multiple experimental drugsJieun Park, Jae Won LeeJournal of Biopharmaceutical Statistics|July 13, 2026
Overview of dose-finding designs and trials in cell and gene therapiesRevathi Ananthakrishnan, Bambang Adiwijaya, Alan Y Chiang, et al.Journal of Biopharmaceutical Statistics|March 11, 2014
Cost-effectiveness analysis: a proposal of new reporting standards in statistical analysisHeejung Bang, Hongwei ZhaoJournal of Biopharmaceutical Statistics|June 19, 2026
Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effectsSean Yiu, Kirsty RhodesJournal of Biopharmaceutical Statistics|April 5, 2014
Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trialAklilu Habteab Ghebretinsae, Geert Molenberghs, Alex Dmitrienko, et al.Journal of Biopharmaceutical Statistics|June 23, 2026
Leveraging external controls in clinical trials: estimands, estimation, assumptionsBo Liu, Fan Li, Rury R Holman, et al.Journal of Biopharmaceutical Statistics|June 1, 2026
Nonparametric estimation of a biometric function using neoteric ranked set sampling with application to breast cancer dataLeila Jabari Koopaei, Ehsan Zamanzade, Afshin ParvardehJournal of Biopharmaceutical Statistics|June 1, 2026
Order-of-addition in mixture and component-amount designs in orthogonal blocksTaha Hasan, Touqeer AhmadJournal of Biopharmaceutical Statistics|June 5, 2026
Non-inferiority testing for the odds ratio in two independent binomial proportions using the method of variance estimates recoveryHuida Chen, Dongsheng Wang, Yutong Wu, et al.Journal of Biopharmaceutical Statistics|September 21, 2020
Empirical likelihood-based inferences for median medical cost regression models with censored dataGuanhao Wei, Gengsheng QinPageof 217